← Coach — Cardiology · Coach hub

Coach — Hypertension: Pressure as Readout, Resistance as Scar

On this hypothesis, blood pressure is a readout of how well the body is matching energy delivery to demand, and chronic high resistance is the scar left when that matching fails.

Primary, or essential, hypertension is usually described as a problem of vessel tone, sodium handling by the kidney, an overactive sympathetic nervous system, and the renin–angiotensin system. Treatment follows from that description: lifelong medicines aimed at each of those levers. That description is useful, and the drugs are valuable. This hypothesis argues that it is also incomplete.

Modern medicine measures the dashboard. Blood pressure, LDL, glucose, weight, and even inflammation are downstream compensations. The engine is the capacity to make ATP. When that engine has headroom, tissues repair and the vessel wall stays competent. When it does not, the body enters a chronic compensatory mode, and the named diseases arrive later as archives of that failure. The proposal here is that mitochondrial energy failure and redox imbalance are the upstream driver of much primary hypertension. Cuff pressure is a form. The function underneath is whether mitochondria are paid in ATP relative to load.

The toll-keeper and the plumbing

The starting point is the chemiosmotic view of life. Food electrons step down the mitochondrial electron transport chain, the energy powers proton pumps, and protons flow back through ATP synthase, which collects a toll of roughly three ATP for every ten protons that cross the membrane. Everything that looks like physiology, vascular tone included, sits downstream of whether that toll-keeper has oxygen, fuel, and an intact membrane.

Vessels exist to deliver the two things the toll-keeper cannot do without: oxygen and fuel. Seen this way, the circulation is not a separate system. It is the plumbing without which the engine cannot run. Treating the vessel only as a pressure gadget is, in this view, the central category error of form-first medicine.

The organizing rule is the compensatory cascade. When ATP load exceeds the capacity to make it, the body falls back on older, less flexible ways of making and spending energy. In an emergency that is adaptive: it saves the hour. If capacity is restored in time, the system stands down. If the mismatch persists, the same emergency programs become a chronic operating mode, and remodeling can lock them in. That locked state is what we meet in clinic as disease.

Nitric oxide as flux manager

Nitric oxide (NO) is taught as a vasodilator, and that is true. The endothelium senses shear and stretch, makes NO, and the smooth muscle in the vessel wall relaxes. On this hypothesis, though, NO is better understood as an energy-flux manager: a short-lived gas whose job is to keep mitochondrial ATP production aligned with tissue load. It does that in three acts.

The first act is delivery. Working tissue opens its small arterioles, flow in the feeding artery rises, the endothelium senses the shear and makes more NO, and the feed arteries widen so the whole tree opens together. Over hours to days, the same shear writes more of the enzyme that makes NO. Regular high energy flux, which is to say training, is the instruction that keeps the delivery system competent. The second act is rationing: the same NO partly and reversibly slows the last enzyme of the electron transport chain in the cells nearest the capillary, so oxygen is spared to reach deeper tissue. The third act is conduit protection: low, steady NO keeps white cells and platelets from sticking, limits leakiness and lipoprotein entry, and restrains smooth-muscle growth. A lumen that stays clean is a lumen that can still deliver.

What exercise shows

Mean arterial pressure is cardiac output times total peripheral resistance. During exercise those terms move in opposite directions. Resistance in the working muscle falls, cardiac output rises several-fold, and because the rise in flow exceeds the fall in resistance, pressure usually rises even while the muscle is wide open. The pressure rise is the residue of driving a large flow through a still-finite arterial tree. It is not the purpose. The purpose is delivery. After the bout, pressure often falls, and repeated bouts write more of the NO enzyme and more mitochondrial volume. That is hormesis and good compensation.

Two errors follow if this is misread. One is to treat the exercise pressure rise as hypertension doing its job, as if pressure were the variable being matched. Flow is the matching variable. The other is to treat chronic hypertension as the same act left running. It is not. In established essential hypertension, resistance is high and cardiac output is normal or low. The patient is paying a pressure tax without buying proportional tissue perfusion. That is failed matching, not completed compensation.

Compensation that becomes a scar

The hypothesis keeps both readings at once. When fuel, timing, and load drift away from what the body evolved for, energy-making capacity falls relative to demand, and the system raises pressure to keep flow through energy-starved vessels, an ancient compensatory reflex now sustained chronically. That first move is an attempt at compensation. But it does not pay the tissue back. Left on, it becomes architecture.

In this model a scar is locked-in tissue and set-point change after a compensatory loop has run outside the window it was built for. Three things lock the high-pressure state in place. The valve stays stiff: energy and redox failure in the endothelium uncouple the enzyme that makes NO, so the vessel cannot drop its resistance when load rises. The wall remodels: more collagen, less elastin, thicker smooth muscle, and stiffer conduit arteries that raise systolic pressure. And the kidney resets its pressure–sodium balance around the new pressure, while sympathetic and renin–angiotensin tone keep the set point high.

What is not accurate, on this view, is to say the body is choosing higher blood pressure so that mitochondria get more ATP. Pressure is the readout. Hypertension is usually a delivery-system scar that then makes the ratio of ATP output to demand worse. And it is not a failure in one place: kidney, nerves, endothelium, and smooth muscle all run matching programs, and endothelial energy failure can start several of them at once.

Inside a failing endothelium

Reduced NO availability is a hallmark of hypertension. The metabolic question is why the NO fails. On this hypothesis, a central mechanism is uncoupling: mitochondrial reactive oxygen species oxidize the cofactor BH4, and the enzyme that should make NO makes superoxide instead. The delivery manager becomes a cause of the damage it was meant to prevent. That is also why simply flooding the system with NO is not a clean fix. The signal is not the enemy; the inefficient, uncoupled enzyme is.

Several inputs push the endothelium toward this failure, on this account: chronically high insulin and seed-oil-dominant eating patterns, linoleic-acid oxidation products, the oxidized cargo of Lp(a) particles, smoking, and a leaky, imbalanced gut. Disturbed, oscillating flow at branch points switches on inflammatory programs, and that is where plaques begin. The geometry of flow writes the biology of the wall.

The wall then joins in. Macrophages move in and amplify oxidative stress and inflammation, the matrix stiffens with fragmented elastic fibers and excess collagen, and smooth muscle leaves its contractile, oxidative state for a synthetic, glycolytic one. Stiffness feeds back mechanically into more matrix. Calcification belongs to the same story, read here as mitochondrial calcium mishandling driven by energy failure.

Kidney, salt, insulin, and sleep

The kidney is ATP-hungry for sodium transport and fails when its mitochondria and their oxygen supply fail. Salt, in this framing, is not merely a volume expander: excess sodium, especially in an insulin-resistant or energy-constrained person, damages mitochondrial structure and function and raises reactive oxygen species, which uncouple the NO enzyme and impair sodium excretion. Salt sensitivity is strongly associated with insulin resistance; roughly half of salt-sensitive individuals are insulin resistant. Over time, sustained high resistance and a reset set point produce a secondary scar in the kidney itself, which then feeds back on volume and pressure control.

Insulin follows the same grammar. A short burst of high insulin is compensation; chronically high insulin is the loop left on. The endothelium that needs a coupled NO enzyme now lives in a high-insulin, high-oxidant milieu that uncouples it. The dose that saved the hour becomes the milieu that ruins the decade. On this hypothesis, that shared upstream driver is why insulin resistance, obesity, and abnormal blood fats travel with hypertension. Obstructive sleep apnea adds repeated cycles of low oxygen and reoxygenation that damage the electron transport chain and drive sympathetic activation.

The heart, pregnancy, and the lungs

The heart is an obligatory oxidative organ, and pressure overload pushes it into compensatory thickening that the same mitochondrial attrition then limits, with fibrosis as the cheaper repair. Preeclampsia can be read as a pregnancy-specific, accelerated version of the same scar, centered on placental mitochondrial stress and reduced NO. Pulmonary arterial hypertension shows its own glycolytic shift in the vessel wall and the right ventricle. In each case the hypothesis places the problem on the same energy-flux and NO map, while conventional care keeps its role; in pregnancy, treatment stays under obstetric guidance.

The eye as a window

The hypothesis draws a close parallel between hypertension and primary open-angle glaucoma: both involve endothelial-like cells that regulate tone, a central reliance on NO, immune participation, and stiffening matrix. In the eye’s drainage pathway, rising eye pressure increases shear in Schlemm’s canal, NO relaxes the outflow tissue, outflow increases, and pressure falls, a feedback loop that parallels the one in blood vessels. Blood flow to the optic nerve head depends on roughly the difference between arterial pressure and eye pressure, and night-time dips in blood pressure meet night-time peaks in eye pressure at the disc. On this hypothesis, the two conditions look less like coincidences and more like cousins. The retina also shows high blood pressure directly: arteriolar narrowing, nicking, hemorrhages, and cotton-wool spots are the visible retinal counterpart of the same vessel damage. Swelling of the optic disc with very high blood pressure is a medical emergency that needs same-day care. Lowering eye pressure is still the only treatment proven to slow glaucoma, and changes to blood-pressure or glaucoma medicines, including bedtime dosing, belong with your physician.

How the hypothesis could be tested

On this hypothesis, blood pressure belongs on a wider dashboard beside night-time dipping, insulin and glucose markers, inflammation, waist-to-height, lean mass, grip, fitness, and overnight heart rate. Map is not terrain. The hypothesis also makes predictions: people with hypertension should show markers of mitochondrial dysfunction, mitochondria-targeted interventions should improve vascular compliance beyond what pressure lowering alone achieves, and if chronic hypertension were successful ATP compensation, raising pressure would raise tissue ATP. It does not, in any simple way.

Where conventional care fits

None of this removes the place of conventional treatment. The major drug classes lower the pressure readout by different routes, and lowering pressure lowers load, which is a real benefit; intensive lowering reduces cardiovascular events in selected high-risk groups. Secondary causes are uncommon but must be considered, and that evaluation belongs with a physician. What the hypothesis adds is that lowering the number does not, by itself, prove engine repair. A lighter car with a worn engine still wins some races; it does not become a new engine. Blood-pressure medicines, their doses, and their timing are decisions to make with your own physician. Nothing here is a reason to stop or change one.

The hypothesis then turns to the conditions the engine evolved for, the three EnSurf pillars. Fuel the mitochondria and gut biota can oxidize cleanly, which on this view reduces the electron leak that uncouples the NO enzyme. Circadian alignment, because the NO enzyme, its cofactor, and mitochondrial quality control all run on a daily cycle, and night-time pressure dipping matters. Strength and conditioning, because resistance and aerobic work are the shear and load signals that write more of the NO enzyme and more mitochondria. The hypothesis calls exercise an endothelial gene-expression therapy and a mitochondrial biogenesis therapy at once, and notes that pulses matter more than constant exposure. Any change to diet, fasting, or training when you take blood-pressure medicines is one to make with your own physician; a long fast in someone whose medicines assume a fed insulin level is a larger perturbation with a narrower safety margin.

The number is a readout

Primary hypertension, on this hypothesis, is not a disease of a number. It is the chronic chapter of a matching circuit. The acute response, raising pressure to keep flow through underpowered tissue, belongs to the good side of the cascade. The standing high-pressure state is a scar: high resistance and a reset kidney. Lowering pressure is often necessary and remains a physician’s decision. It does not, by itself, recouple the enzyme. This is a hypothesis, not medical advice. If you live with high blood pressure, talk with your own physician about your own numbers and your own treatment.

A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 29, 2026.

Related: Cardiology · Heart Failure · Pulmonary · Fuel · Glaucoma (extended report) · Fuchs’ Dystrophy · Arterial and Venous Occlusions. Full version: the extended report, A Metabolic Hypothesis of Hypertension.

See the notice at the top of this page. Working hypothesis, not medical advice.